No data available.
Please log in to see this content.
You have no subscription access to this content.
The full text of this article is not currently available.
ワーファリン服用心臓血管病患者に対するナットウキナーゼ併用の安全性と効果の研究
Rent:
Rent this article for
JPY
Abstract
We have evaluated nattokinase effects in 60 adult cardiovascular patients with warfarin by double blind method. Clinical symptoms(a short of breath, a walking condition, coldness of hand and foot, a color and gloss of skin)and the various biochemical data(APTT, PT, Ddimer, PIC, PAI−1, high sensitivity CRP)have improved in some of these patients with warfarin in spite of dosage of low dose(1700FU)or high dose(3400FU)of nattokinase. There are not recognized in side effect in all patients with nattokinase. Nattokinase might be useful in not only elderly patients with the low dose but also serious younger patient with the high dose. In conclusion, proper use of nattokinase could be suggested strongly effective, and safe in cardiac patient with warfarin.(Jpn Pharmacol Ther 2008;36:453−64) KEY WORDS Nattokinase, Warfarin, Combined effect, Cardiovascular patients
Full text loading...
/content/article/0386-3603/36050/453